FDA approves drug for hospital-acquired pneumonia May 24, 2023 AutoBot Uncategorized 0 On May 23, the FDA approved a new drug intended to treat hospital-acquired pneumonia and ventilator-associated pneumonia caused by Acinetobacter baumannii-calcoaceticus, a critical bacterial pathogen.